Prognostic significance of AKT/mTOR signaling in advanced neuroendocrine tumors treated with somatostatin analogs.
about
Everolimus-based combination for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): biological rationale and critical review of published data.Guidelines for biomarker testing in gastroenteropancreatic neuroendocrine neoplasms: a national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.Somatostatin Analogue Treatment Primarily Induce miRNA Expression Changes and Up-Regulates Growth Inhibitory miR-7 and miR-148a in Neuroendocrine Cells
P2860
Prognostic significance of AKT/mTOR signaling in advanced neuroendocrine tumors treated with somatostatin analogs.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Prognostic significance of AKT ...... ted with somatostatin analogs.
@ast
Prognostic significance of AKT ...... ted with somatostatin analogs.
@en
type
label
Prognostic significance of AKT ...... ted with somatostatin analogs.
@ast
Prognostic significance of AKT ...... ted with somatostatin analogs.
@en
prefLabel
Prognostic significance of AKT ...... ted with somatostatin analogs.
@ast
Prognostic significance of AKT ...... ted with somatostatin analogs.
@en
P2093
P2860
P50
P356
P1476
Prognostic significance of AKT ...... ted with somatostatin analogs.
@en
P2093
Adília Costa
Afonso Fernandes
Ana C Santos
Ana R Fernandes
António Quintela
Madalena Ramos
Mara Santos
P2860
P304
P356
10.2147/OTT.S36330
P407
P577
2012-11-28T00:00:00Z